Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma

M De Martino, S Pellecchia, M Decaussin-Petrucci… - Cell Cycle, 2023 - Taylor & Francis
Anaplastic thyroid carcinoma (ATC) is one of the most aggressive and lethal neoplasms in
humans, and just limited progresses have been made to extend patient survival and …

Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma

D Martino, M Da Costa - Cell Cycle, 2023 - ingentaconnect.com
Anaplastic thyroid carcinoma (ATC) is one of the most aggressive and lethal neoplasms in
humans, and just limited progresses have been made to extend patient survival and …

[PDF][PDF] Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma

M De Martino, S Pellecchia, M Decaussin-Petrucci… - 2024 - iris.unina.it
Anaplastic thyroid carcinoma (ATC) is one of the most aggressive and lethal neoplasms in
humans, and just limited progresses have been made to extend patient survival and …

Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma

M De Martino, S Pellecchia, M Decaussin-Petrucci… - CELL …, 2023 - iris.unicampania.it
Anaplastic thyroid carcinoma (ATC) is one of the most aggressive and lethal neoplasms in
humans, and just limited progresses have been made to extend patient survival and …

Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma

M De Martino, S Pellecchia… - Cell cycle …, 2023 - pubmed.ncbi.nlm.nih.gov
Anaplastic thyroid carcinoma (ATC) is one of the most aggressive and lethal neoplasms in
humans, and just limited progresses have been made to extend patient survival and …

Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma

M De Martino, S Pellecchia, M Decaussin-Petrucci… - CELL CYCLE, 2023 - iris.unina.it
: Anaplastic thyroid carcinoma (ATC) is one of the most aggressive and lethal neoplasms in
humans, and just limited progresses have been made to extend patient survival and …